RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, is pleased to announce that Dr. R. Eric McAllister, the company’s Vice President of Clinical Development and Chief Medical Officer, has been named as one of R&D Directions' "Most Notable People in R&D.”
